Another study reported eosinopenia (<0.02 109/L) alone or in combination with elevated high-sensitivity C-reactive protein (≥4 mg/L) could be used for separating the two groups and thus providing a biomarker with predictive capacity for diagnosing COVID-19 [18]. The gene discussed is CRP; the disease is COVID-19.